ADA2 and cancer: Significant alterations in both ADA iso-enzyme activities (ADA1 and ADA2) have been found as a result of TNBC cell interactions with macrophages, lymphocytes, and endothelial cells in vitro providing an unfavorable phenotype related to cancer progression.